Is Modalert Effective for ADHD?

Provigil is a fascinating drug. It keeps narcoleptics from falling asleep and it also seems to help people who have Attention Deficit Disorder (ADD) and Attention Deficit Hyperactive Disorder (ADHD) remain concentrated.
But how successful is Provigil for ADHD? That depends totally since Provigil has revealed mixed results in studies related to ADHD treatment on which study you review. The outcomes of one study published in July 2000 were so unsatisfactory the maker of the drugs, Cephalon Inc., determined to pursue other indicators for the drug. Subsequently, in February 2001, the Journal of the American Academy of Child and Adolescent Psychiatry published the outcomes of a study that demonstrated possible advantage of Modalert as a once-daily ADHD treatment. The latest research, performed by producer in a attempt to get FDA approval, demonstrated “significant progress” when compared to a placebo.
Your body is going to work as the top judge of the worth as an ADD and ADHD treatment of Provigil. However, before you run to your doctor’s office asking for a prescription, there are warnings and side effects you have to know about.
Provigil may be habit forming and has got the possibility for addiction and misuse. You need to talk about the addiction and abuse potential of Provigil together with your doctor. This drug must not be taken by anyone that has been or presently is dependent on drugs or booze.
Symptoms of a Provigil overdose might include excitation, agitation, sleeplessness, sleep disturbances, stress, irritability, aggressiveness, confusion, nervousness, tremor, palpitations, nausea, and diarrhea.
Now about 20,000 individuals use Provigil off label – to treat the symptoms of ADHD. Doctors frequently prescribe drugs “off label,” meaning they prescribe the drug for a condition other than what was accepted by the FDA. Though it is legal for physicians to prescribe drugs off-label, it is prohibited for the drug makers to promote their drugs for off-label uses.
Provigil’s producer, Cephalon Inc., has requested FDA approval for Attenace, a reformulation using Provigil’s active ingredient, modafinil. By achieving FDA approval for Attenace Cephalon will soon be permitted to advertise Modafinil for ADHD. Attenace is likely to reach pharmacy shelves in early 2006.